There are currently 53 clinical trials in Waco, Texas looking for participants to engage in research studies. Trials are conducted at various facilities, including GSK Investigational Site, Texas Oncology, Allergy Asthma Research Institute and Teva Investigational Site 14948. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Brain Substrates for Cardiovascular Stress Physiology
NCT05298956
Recruiting
Transcranial infrared laser stimulation is a non-invasive neuromodulation technique. The study will examine the effect of transcranial infrared laser stimulation on cardiovascular and metabolic responses to stress.
Gender:
All
Ages:
Between 18 years and 30 years
Trial Updated:
07/28/2023
Locations: Annie T. Ginty, Waco, Texas
Conditions: Stress Reaction
Register for Updates
Speech Perception in Bimodal Hearing
NCT05599165
Recruiting
The protocol has two aims; Aim 1 involves two experiments and Aim 2 involves three experiments. Under Aim 1, the investigator will identify that the frequency and time ranges of consonants produce consonant enhancement (i.e., "target frequency range" and "target time range", respectively), and that the frequency and time ranges of consonants cause consonant confusions (i.e., "conflicting frequency range" and "conflicting time range", respectively). Aim 2 tests the effects of the frequency and ti... Read More
Gender:
All
Ages:
Between 18 years and 74 years
Trial Updated:
10/25/2022
Locations: Yang-Soo Yoon, Waco, Texas
Conditions: Hearing Loss, Sensorineural
Register for Updates
Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis
NCT04880187
Recruiting
This study will compare the effects of AXA1125, an orally active mixture of amino acids, compared to placebo, on improving fat and inflammation (steatohepatitis) as well as fibrosis in subjects with non alcoholic steatohepatitis (NASH). as well as the safety and tolerability of AXA1125. Subjects will take one of two different doses of AXA1125 or a placebo twice daily, and a liver biopsy will be done at the beginning and end of the 48-week study.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/07/2022
Locations: Impact Clinical Research, Waco, Texas
Conditions: Non Alcoholic Steatohepatitis (NASH)
Register for Updates
Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
NCT02061436
Recruiting
Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, investigator initiated registry is to collect information on treatment strategies and outcomes of consecutive patients undergoing CTO PCI among various participating centers. The information collected will be used to deter... Read More
Gender:
All
Ages:
All
Trial Updated:
03/08/2022
Locations: Providence Health Center, Waco, Texas
Conditions: Coronary Artery Disease
Register for Updates
On Site Sensors Monitoring Impacts of Cognitive Decline on ADLs
NCT04871698
Recruiting
The purpose of this research is to compare the effectiveness of a continuous monitoring system to assess Activities of Daily Living (ADLs) over time compared to the traditional assessments used by medical professionals as Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) progresses.
Gender:
All
Ages:
65 years and above
Trial Updated:
04/29/2021
Locations: Birkeland Current, Waco, Texas
Conditions: Dementia, Dementia Alzheimers
Register for Updates